Once-daily QVA149 significantly improves lung function and symptoms compared to twice-daily fluticasone/salmeterol in COPD patients: The ILLUMINATE study
- Resource Type
- Journal
- Source
EUROPEAN RESPIRATORY JOURNAL ; SEP 1 2012, 40 2p. Supplement: 56- Subject
- Language
- English
- ISSN
- 13993003